(Q38382072)

English

Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386).

scientific article published on 04 March 2015

Statements

Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386). (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit